Cargando…
Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethanolic (polymorph I) and methanolic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete molecule in the asymmetric unit. The mai...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057381/ https://www.ncbi.nlm.nih.gov/pubmed/32148889 http://dx.doi.org/10.1107/S2056989020002406 |
_version_ | 1783503643792637952 |
---|---|
author | Daoui, Said Baydere, Cemile Chelfi, Tarik El Kalai, Fouad Dege, Necmi Karrouchi, Khalid Benchat, Noureddine |
author_facet | Daoui, Said Baydere, Cemile Chelfi, Tarik El Kalai, Fouad Dege, Necmi Karrouchi, Khalid Benchat, Noureddine |
author_sort | Daoui, Said |
collection | PubMed |
description | Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethanolic (polymorph I) and methanolic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete molecule in the asymmetric unit. The main difference between the molecules of (I) and (II) is the reversed position of the hydroxy group of the carboxylic function. All other conformational features are found to be similar in the two molecules. The different orientation of the OH group results in different hydrogen-bonding schemes in the crystal structures of (I) and (II). Whereas in (I) intermolecular O—H⋯O hydrogen bonds with the pyridazinone carbonyl O atom as acceptor generate chains with a C(7) motif extending parallel to the b-axis direction, in the crystal of (II) pairs of inversion-related O—H⋯O hydrogen bonds with an R (2) (2)(8) ring motif between two carboxylic functions are found. The intermolecular interactions in both crystal structures were analysed using Hirshfeld surface analysis and two-dimensional fingerprint plots. |
format | Online Article Text |
id | pubmed-7057381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-70573812020-03-06 Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses Daoui, Said Baydere, Cemile Chelfi, Tarik El Kalai, Fouad Dege, Necmi Karrouchi, Khalid Benchat, Noureddine Acta Crystallogr E Crystallogr Commun Research Communications Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethanolic (polymorph I) and methanolic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete molecule in the asymmetric unit. The main difference between the molecules of (I) and (II) is the reversed position of the hydroxy group of the carboxylic function. All other conformational features are found to be similar in the two molecules. The different orientation of the OH group results in different hydrogen-bonding schemes in the crystal structures of (I) and (II). Whereas in (I) intermolecular O—H⋯O hydrogen bonds with the pyridazinone carbonyl O atom as acceptor generate chains with a C(7) motif extending parallel to the b-axis direction, in the crystal of (II) pairs of inversion-related O—H⋯O hydrogen bonds with an R (2) (2)(8) ring motif between two carboxylic functions are found. The intermolecular interactions in both crystal structures were analysed using Hirshfeld surface analysis and two-dimensional fingerprint plots. International Union of Crystallography 2020-02-25 /pmc/articles/PMC7057381/ /pubmed/32148889 http://dx.doi.org/10.1107/S2056989020002406 Text en © Daoui et al. 2020 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Research Communications Daoui, Said Baydere, Cemile Chelfi, Tarik El Kalai, Fouad Dege, Necmi Karrouchi, Khalid Benchat, Noureddine Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title | Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title_full | Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title_fullStr | Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title_full_unstemmed | Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title_short | Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses |
title_sort | polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and hirshfeld surface analyses |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057381/ https://www.ncbi.nlm.nih.gov/pubmed/32148889 http://dx.doi.org/10.1107/S2056989020002406 |
work_keys_str_mv | AT daouisaid polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT bayderecemile polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT chelfitarik polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT elkalaifouad polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT degenecmi polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT karrouchikhalid polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses AT benchatnoureddine polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses |